Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce L Davidson

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
Thrombosis and Haemostasis|January 10, 2009
A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT)Alexander G G Turpie, Kenneth A Bauer, Bruce L Davidson, et al.
Thrombosis and Haemostasis|February 1, 2007
Accuracy of compression ultrasound in screening for deep venous thrombosis in acutely ill medical patientsWitold Z Tomkowski, Bruce L Davidson, Joanna Wisniewska, et al.
The New England Journal of Medicine|May 28, 2004
Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolismVittorio Pengo, Anthonie W A Lensing, Martin H Prins, et al.
Thrombosis and Haemostasis|April 8, 2009
Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trialsFrederiek F van Doormaal, Gary E Raskob, Bruce L Davidson, et al.
American Journal of Respiratory and Critical Care Medicine|August 9, 2003
Endoscopic ultrasound, positron emission tomography, and computerized tomography for lung cancerAnnette Fritscher-Ravens, Bruce L Davidson, Hans-Peter Hauber, et al.
Thrombosis and Haemostasis|May 29, 2010
Idraparinux versus standard therapy in the treatment of deep venous thrombosis in cancer patients: a subgroup analysis of the Van Gogh DVT trialFrederiek F van Doormaal, Alexander T Cohen, Bruce L Davidson, et al.
The Clinical Respiratory Journal|January 27, 2015
Inverse relationship of bleeding risk with clot burden during pulmonary embolism treatment with LMW heparinChen Wang, Zhenguo Zhai, Yuanhua Yang, et al.
JAMA|February 11, 2005
Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trialJean-Noel Fiessinger, Menno V Huisman, Bruce L Davidson, et al.
BMJ (Clinical Research Ed.)|January 28, 2006
Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trialAlexander T Cohen, Bruce L Davidson, Alexander S Gallus, et al.
Chest|March 12, 2011
Prevalence and risk of preexisting heparin-induced thrombocytopenia antibodies in patients with acute VTETheodore E Warkentin, Bruce L Davidson, Harry R Büller, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Thrombosis and Haemostasis|January 10, 2009
A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT)Alexander G G Turpie, Kenneth A Bauer, Bruce L Davidson, et al.
Thrombosis and Haemostasis|February 1, 2007
Accuracy of compression ultrasound in screening for deep venous thrombosis in acutely ill medical patientsWitold Z Tomkowski, Bruce L Davidson, Joanna Wisniewska, et al.
The New England Journal of Medicine|May 28, 2004
Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolismVittorio Pengo, Anthonie W A Lensing, Martin H Prins, et al.
Thrombosis and Haemostasis|April 8, 2009
Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trialsFrederiek F van Doormaal, Gary E Raskob, Bruce L Davidson, et al.
American Journal of Respiratory and Critical Care Medicine|August 9, 2003
Endoscopic ultrasound, positron emission tomography, and computerized tomography for lung cancerAnnette Fritscher-Ravens, Bruce L Davidson, Hans-Peter Hauber, et al.
Thrombosis and Haemostasis|May 29, 2010
Idraparinux versus standard therapy in the treatment of deep venous thrombosis in cancer patients: a subgroup analysis of the Van Gogh DVT trialFrederiek F van Doormaal, Alexander T Cohen, Bruce L Davidson, et al.
The Clinical Respiratory Journal|January 27, 2015
Inverse relationship of bleeding risk with clot burden during pulmonary embolism treatment with LMW heparinChen Wang, Zhenguo Zhai, Yuanhua Yang, et al.
JAMA|February 11, 2005
Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trialJean-Noel Fiessinger, Menno V Huisman, Bruce L Davidson, et al.
BMJ (Clinical Research Ed.)|January 28, 2006
Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trialAlexander T Cohen, Bruce L Davidson, Alexander S Gallus, et al.
Chest|March 12, 2011
Prevalence and risk of preexisting heparin-induced thrombocytopenia antibodies in patients with acute VTETheodore E Warkentin, Bruce L Davidson, Harry R Büller, et al.
Pageof 8